InxMed Co., Ltd. announced that IN10018 had been granted with Breakthrough Therapy Designation

International Business News   –  InxMed Co., Ltd. announced that IN10018, its focal adhesion kinase (FAK) inhibitor, had been granted with… More »

Sciwind Biosciences Co., Ltd. announced the initiation of subject dosing in its Phase 1 clinical trial of XW004

International Business News   –  Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to… More »

TauRx Pharmaceuticals Ltd has announced that the last patient has completed treatment

International Business News   –  TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer’s Disease (AD) research, has announced that the… More »

Ascentage Pharma announced that it has presented the latest results from six preclinical studies

International Business News   –  Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis… More »

Harbour BioMed announced the appointment of Dr. Humphrey Gardner as Chief Medical Officer

International Business News   –   Harbour BioMed (“HBM” or the “Company”; HKEX: 02142), today announced the appointment of Dr. Humphrey Gardner as Chief Medical… More »

China Medical System announced its annual results

International Business News   –  Recently, China Medical System (“CMS”, 0867.HK) announced its annual results. After recording continuous performance growth in… More »

Gracell Biotechnologies Inc. announced that its abstract providing the follow-up clinical data of GC012F

International Business News   –  Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to… More »

By using BGI’s independently-developed DNBelab C4 single-cell library platform

International Business News   –  In a breakthrough that could lead to scientific advancement in the treatment of human diseases, researchers… More »

Akeso, Inc. announced the publication of preclinical results of its anti-TIGIT monoclonal antibody

International Business News   –  Akeso, Inc. (9926.HK) ( “Akeso” ), a China-based biopharmaceutical company focusing on the development and commercialization… More »

Akeso, Inc. announced the publication of preclinical results of its PD-1/LAG-3 bi-specific antibody

International Business News   –  Akeso, Inc. (9926.HK) ( “Akeso” ), a China-based biopharmaceutical company focusing on the development and commercialization… More »